Copyright Reports & Markets. All rights reserved.

Global Cell-free DNA Testing Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cell-free DNA Testing Service by Type
    • 1.3.1 Overview: Global Cell-free DNA Testing Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Cell-free DNA Testing Service Consumption Value Market Share by Type in 2025
    • 1.3.3 Targeted Sequencing
    • 1.3.4 Whole Genome Sequencing
  • 1.4 Classification of Cell-free DNA Testing Service by Target Audiences
    • 1.4.1 Overview: Global Cell-free DNA Testing Service Market Size by Target Audiences: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Cell-free DNA Testing Service Consumption Value Market Share by Target Audiences in 2025
    • 1.4.3 LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
    • 1.4.4 DTC (Direct-to-Consumer) Services for Consumers
  • 1.5 Classification of Cell-free DNA Testing Service by Targets for Detection
    • 1.5.1 Overview: Global Cell-free DNA Testing Service Market Size by Targets for Detection: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Cell-free DNA Testing Service Consumption Value Market Share by Targets for Detection in 2025
    • 1.5.3 Cell-free Fetal DNA (Fetal cfDNA)
    • 1.5.4 Circulating Tumor DNA (ctDNA)
    • 1.5.5 Donor-derived cfDNA (dd-cfDNA)
  • 1.6 Global Cell-free DNA Testing Service Market by Application
    • 1.6.1 Overview: Global Cell-free DNA Testing Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Prenatal Testing
    • 1.6.3 Oncology
    • 1.6.4 Organ Transplant Monitoring
    • 1.6.5 Others
  • 1.7 Global Cell-free DNA Testing Service Market Size & Forecast
  • 1.8 Global Cell-free DNA Testing Service Market Size and Forecast by Region
    • 1.8.1 Global Cell-free DNA Testing Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Cell-free DNA Testing Service Market Size by Region, (2021-2032)
    • 1.8.3 North America Cell-free DNA Testing Service Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Cell-free DNA Testing Service Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Cell-free DNA Testing Service Market Size and Prospect (2021-2032)
    • 1.8.6 South America Cell-free DNA Testing Service Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Cell-free DNA Testing Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Natera
    • 2.1.1 Natera Details
    • 2.1.2 Natera Major Business
    • 2.1.3 Natera Cell-free DNA Testing Service Product and Solutions
    • 2.1.4 Natera Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Natera Recent Developments and Future Plans
  • 2.2 CareDx
    • 2.2.1 CareDx Details
    • 2.2.2 CareDx Major Business
    • 2.2.3 CareDx Cell-free DNA Testing Service Product and Solutions
    • 2.2.4 CareDx Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 CareDx Recent Developments and Future Plans
  • 2.3 BillionToOne, Inc.
    • 2.3.1 BillionToOne, Inc. Details
    • 2.3.2 BillionToOne, Inc. Major Business
    • 2.3.3 BillionToOne, Inc. Cell-free DNA Testing Service Product and Solutions
    • 2.3.4 BillionToOne, Inc. Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 BillionToOne, Inc. Recent Developments and Future Plans
  • 2.4 ARUP Laboratories
    • 2.4.1 ARUP Laboratories Details
    • 2.4.2 ARUP Laboratories Major Business
    • 2.4.3 ARUP Laboratories Cell-free DNA Testing Service Product and Solutions
    • 2.4.4 ARUP Laboratories Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 ARUP Laboratories Recent Developments and Future Plans
  • 2.5 Guardant Health
    • 2.5.1 Guardant Health Details
    • 2.5.2 Guardant Health Major Business
    • 2.5.3 Guardant Health Cell-free DNA Testing Service Product and Solutions
    • 2.5.4 Guardant Health Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Guardant Health Recent Developments and Future Plans
  • 2.6 GRAIL
    • 2.6.1 GRAIL Details
    • 2.6.2 GRAIL Major Business
    • 2.6.3 GRAIL Cell-free DNA Testing Service Product and Solutions
    • 2.6.4 GRAIL Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 GRAIL Recent Developments and Future Plans
  • 2.7 Foundation Medicine
    • 2.7.1 Foundation Medicine Details
    • 2.7.2 Foundation Medicine Major Business
    • 2.7.3 Foundation Medicine Cell-free DNA Testing Service Product and Solutions
    • 2.7.4 Foundation Medicine Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Foundation Medicine Recent Developments and Future Plans
  • 2.8 BGI Genomics
    • 2.8.1 BGI Genomics Details
    • 2.8.2 BGI Genomics Major Business
    • 2.8.3 BGI Genomics Cell-free DNA Testing Service Product and Solutions
    • 2.8.4 BGI Genomics Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 BGI Genomics Recent Developments and Future Plans
  • 2.9 Berry Genomics
    • 2.9.1 Berry Genomics Details
    • 2.9.2 Berry Genomics Major Business
    • 2.9.3 Berry Genomics Cell-free DNA Testing Service Product and Solutions
    • 2.9.4 Berry Genomics Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Berry Genomics Recent Developments and Future Plans
  • 2.10 Burning Rock
    • 2.10.1 Burning Rock Details
    • 2.10.2 Burning Rock Major Business
    • 2.10.3 Burning Rock Cell-free DNA Testing Service Product and Solutions
    • 2.10.4 Burning Rock Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Burning Rock Recent Developments and Future Plans
  • 2.11 ACT Genomics
    • 2.11.1 ACT Genomics Details
    • 2.11.2 ACT Genomics Major Business
    • 2.11.3 ACT Genomics Cell-free DNA Testing Service Product and Solutions
    • 2.11.4 ACT Genomics Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 ACT Genomics Recent Developments and Future Plans
  • 2.12 MedGenome
    • 2.12.1 MedGenome Details
    • 2.12.2 MedGenome Major Business
    • 2.12.3 MedGenome Cell-free DNA Testing Service Product and Solutions
    • 2.12.4 MedGenome Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 MedGenome Recent Developments and Future Plans
  • 2.13 Lucence
    • 2.13.1 Lucence Details
    • 2.13.2 Lucence Major Business
    • 2.13.3 Lucence Cell-free DNA Testing Service Product and Solutions
    • 2.13.4 Lucence Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Lucence Recent Developments and Future Plans
  • 2.14 NIPT by LifeCodexx
    • 2.14.1 NIPT by LifeCodexx Details
    • 2.14.2 NIPT by LifeCodexx Major Business
    • 2.14.3 NIPT by LifeCodexx Cell-free DNA Testing Service Product and Solutions
    • 2.14.4 NIPT by LifeCodexx Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 NIPT by LifeCodexx Recent Developments and Future Plans
  • 2.15 Genodive Pharma
    • 2.15.1 Genodive Pharma Details
    • 2.15.2 Genodive Pharma Major Business
    • 2.15.3 Genodive Pharma Cell-free DNA Testing Service Product and Solutions
    • 2.15.4 Genodive Pharma Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Genodive Pharma Recent Developments and Future Plans
  • 2.16 Riken Genesis
    • 2.16.1 Riken Genesis Details
    • 2.16.2 Riken Genesis Major Business
    • 2.16.3 Riken Genesis Cell-free DNA Testing Service Product and Solutions
    • 2.16.4 Riken Genesis Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Riken Genesis Recent Developments and Future Plans
  • 2.17 GC Genome
    • 2.17.1 GC Genome Details
    • 2.17.2 GC Genome Major Business
    • 2.17.3 GC Genome Cell-free DNA Testing Service Product and Solutions
    • 2.17.4 GC Genome Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 GC Genome Recent Developments and Future Plans
  • 2.18 EDGC
    • 2.18.1 EDGC Details
    • 2.18.2 EDGC Major Business
    • 2.18.3 EDGC Cell-free DNA Testing Service Product and Solutions
    • 2.18.4 EDGC Cell-free DNA Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 EDGC Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cell-free DNA Testing Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Cell-free DNA Testing Service by Company Revenue
    • 3.2.2 Top 3 Cell-free DNA Testing Service Players Market Share in 2025
    • 3.2.3 Top 6 Cell-free DNA Testing Service Players Market Share in 2025
  • 3.3 Cell-free DNA Testing Service Market: Overall Company Footprint Analysis
    • 3.3.1 Cell-free DNA Testing Service Market: Region Footprint
    • 3.3.2 Cell-free DNA Testing Service Market: Company Product Type Footprint
    • 3.3.3 Cell-free DNA Testing Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cell-free DNA Testing Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Cell-free DNA Testing Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Cell-free DNA Testing Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Cell-free DNA Testing Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Cell-free DNA Testing Service Consumption Value by Type (2021-2032)
  • 6.2 North America Cell-free DNA Testing Service Market Size by Application (2021-2032)
  • 6.3 North America Cell-free DNA Testing Service Market Size by Country
    • 6.3.1 North America Cell-free DNA Testing Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Cell-free DNA Testing Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Cell-free DNA Testing Service Consumption Value by Type (2021-2032)
  • 7.2 Europe Cell-free DNA Testing Service Consumption Value by Application (2021-2032)
  • 7.3 Europe Cell-free DNA Testing Service Market Size by Country
    • 7.3.1 Europe Cell-free DNA Testing Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 7.3.3 France Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Cell-free DNA Testing Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cell-free DNA Testing Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Cell-free DNA Testing Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Cell-free DNA Testing Service Market Size by Region
    • 8.3.1 Asia-Pacific Cell-free DNA Testing Service Consumption Value by Region (2021-2032)
    • 8.3.2 China Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 8.3.5 India Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Cell-free DNA Testing Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Cell-free DNA Testing Service Consumption Value by Type (2021-2032)
  • 9.2 South America Cell-free DNA Testing Service Consumption Value by Application (2021-2032)
  • 9.3 South America Cell-free DNA Testing Service Market Size by Country
    • 9.3.1 South America Cell-free DNA Testing Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Cell-free DNA Testing Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cell-free DNA Testing Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Cell-free DNA Testing Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Cell-free DNA Testing Service Market Size by Country
    • 10.3.1 Middle East & Africa Cell-free DNA Testing Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Cell-free DNA Testing Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Cell-free DNA Testing Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Cell-free DNA Testing Service Market Drivers
  • 11.2 Cell-free DNA Testing Service Market Restraints
  • 11.3 Cell-free DNA Testing Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cell-free DNA Testing Service Industry Chain
  • 12.2 Cell-free DNA Testing Service Upstream Analysis
  • 12.3 Cell-free DNA Testing Service Midstream Analysis
  • 12.4 Cell-free DNA Testing Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cell-free DNA Testing Service market size was valued at US$ 11124 million in 2025 and is forecast to a readjusted size of US$ 21205 million by 2032 with a CAGR of 9.8% during review period.
    Cell-free DNA (cfDNA) testing services constitute a category of precision medicine diagnostics that involve collecting bodily fluids—such as blood or urine—to extract DNA fragments found in the extracellular environment. These services employ molecular detection technologies, including next-generation sequencing (NGS), droplet digital PCR (ddPCR), standard PCR, and methylation analysis, to analyze DNA sequence variations, gene mutations, chromosomal abnormalities, and epigenetic information, subsequently providing test reports and medical data interpretation to healthcare providers, research institutions, or individual users. Key applications of cfDNA testing include non-invasive prenatal testing (NIPT; screening for chromosomal abnormalities using fetal cfDNA), cancer liquid biopsy (using circulating tumor DNA, or ctDNA, for early cancer screening, companion diagnostics, and monitoring of minimal residual disease, or MRD), transplant monitoring (detecting donor-derived cfDNA), and genetic disease screening. Compared to traditional tissue biopsies, cfDNA testing offers advantages such as minimally invasive sampling, the feasibility of repeated testing, and the ability to dynamically monitor disease progression, making it a vital technological pathway for liquid biopsy and precision medicine.
    Driven by the rapid advancement of global precision medicine, early cancer screening, personalized therapy, and genetic testing technologies, the market for cfDNA testing services holds significant growth potential. Cancer liquid biopsy is a key driver of this market growth; the detection of ctDNA within the cfDNA pool allows for the identification of tumor-associated genetic alterations in blood samples, facilitating treatment selection, therapeutic efficacy assessment, and recurrence monitoring. Simultaneously, the expanding NIPT market is propelling the commercial application of cfDNA technology in prenatal screening. Looking ahead, as the costs of next-generation sequencing decrease and ultra-sensitive detection technologies (such as methylation analysis, multi-omics analysis, and single-molecule sequencing) mature—and as early cancer screening and MRD testing enter clinical practice—cfDNA testing services are expected to expand beyond traditional prenatal screening into areas such as comprehensive cancer management, genetic disease diagnosis, and general health management, maintaining a trajectory of rapid market growth.
    Report Scope
    This report is a detailed and comprehensive analysis for global Cell-free DNA Testing Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Cell-free DNA Testing Service market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Cell-free DNA Testing Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Cell-free DNA Testing Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Cell-free DNA Testing Service market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cell-free DNA Testing Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cell-free DNA Testing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Natera, CareDx, BillionToOne, Inc., ARUP Laboratories, Guardant Health, GRAIL, Foundation Medicine, BGI Genomics, Berry Genomics, Burning Rock, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Cell-free DNA Testing Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Targeted Sequencing
    Whole Genome Sequencing
    Market segment by Target Audiences
    LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
    DTC (Direct-to-Consumer) Services for Consumers
    Market segment by Targets for Detection
    Cell-free Fetal DNA (Fetal cfDNA)
    Circulating Tumor DNA (ctDNA)
    Donor-derived cfDNA (dd-cfDNA)
    Market segment by Application
    Prenatal Testing
    Oncology
    Organ Transplant Monitoring
    Others
    Market segment by players, this report covers
    Natera
    CareDx
    BillionToOne, Inc.
    ARUP Laboratories
    Guardant Health
    GRAIL
    Foundation Medicine
    BGI Genomics
    Berry Genomics
    Burning Rock
    ACT Genomics
    MedGenome
    Lucence
    NIPT by LifeCodexx
    Genodive Pharma
    Riken Genesis
    GC Genome
    EDGC
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    Chapter Outline
    Chapter 1, to describe Cell-free DNA Testing Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Cell-free DNA Testing Service, with revenue, gross margin, and global market share of Cell-free DNA Testing Service from 2021 to 2026.
    Chapter 3, the Cell-free DNA Testing Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Cell-free DNA Testing Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Cell-free DNA Testing Service.
    Chapter 13, to describe Cell-free DNA Testing Service research findings and conclusion.

    Buy now